Q3 2026 13F filing
Updated 6 days ago46 disclosed positions worth $311.9M
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | D DELCATH SYSTEMS, INC. | $52.7M | 3.30M | 16.90% | — |
| 2 | V VERASTEM INC | $34.1M | 4.24M | 10.94% | — |
| 3 | F FENNEC PHARMACEUTICALS INC | $34M | 3.19M | 10.89% | — |
| 4 | X XERIS BIOPHARMA HOLDINGS INC | $24.7M | 2.58M | 7.92% | — |
| 5 | H CYBIN INC | $17.1M | 1.39M | 5.47% | — |
| 6 | S SAVARA INC | $16.4M | 3.18M | 5.26% | — |
| 7 | Q REPLIMUNE GROUP INC | $13.2M | 1.00M | 4.25% | — |
| 8 | V VOR BIOPHARMA INC | $11.6M | 609.2K | 3.73% | — |
| 9 | M MEDIWOUND LTD | $10.3M | 749.1K | 3.31% | — |
| 10 | ? N/A X4 PHARMACEUTICALS INC | $9.3M | 3.21M | 2.99% | — |
| 11 | A AQUESTIVE THERAPEUTICS INC | $9.3M | 2.00M | 2.97% | — |
| 12 | P VAXCYTE INC | $8.5M | 149.4K | 2.73% | — |
| 13 | T PROTARA THERAPEUTICS INC | $7.3M | 2.40M | 2.35% | — |
| 14 | ? N/A MYOMO INC | $6.1M | 3.92M | 1.96% | — |
| 15 | B BIOCRYST PHARMACEUTICALS INC | $6M | 721.5K | 1.93% | — |
| 16 | R ROCKET PHARMACEUTICALS INC | $5.8M | 2.20M | 1.86% | — |
| 17 | P PEPGEN INC | $4.8M | 2.00M | 1.55% | — |
| 18 | P PROFOUND MEDICAL CORP | $4.8M | 828.1K | 1.54% | — |
| 19 | ? N/A TALPHERA INC | $4.8M | 4.13M | 1.54% | — |
| 20 | N NEURAXIS INC | $4M | 548.1K | 1.30% | — |
| 21 | O OVID THERAPEUTICS INC | $2.8M | 1.11M | 0.88% | — |
| 22 | ? N/A INSPIREMD INC | $2.6M | 3.91M | 0.84% | — |
| 23 | ? N/A ACUMEN PHARMACEUTICALS INC | $2.4M | 1.10M | 0.78% | — |
| 24 | ? N/A EYEPOINT INC | $2.3M | 696.0K | 0.73% | — |
| 25 | A ABIVAX SA | $2.1M | 20.9K | 0.66% | — |
| 26 | B BIOFRONTERA INC | $1.9M | 1.79M | 0.62% | — |
| 27 | F FEMASYS INC | $1.6M | 759.2K | 0.53% | — |
| 28 | A ATEA PHARMACEUTICALS INC | $1.5M | 280.1K | 0.47% | — |
| 29 | C CG ONCOLOGY INC | $1.4M | 20.0K | 0.45% | — |
| 30 | S SPRUCE BIOSCIENCES INC | $1.3M | 26.5K | 0.41% | — |
| 31 | R REGENTIS BIOMATERIALS LTD | $1.3M | 701.7K | 0.41% | — |
| 32 | K KURA ONCOLOGY INC | $1.1M | 100.0K | 0.34% | — |
| 33 | ? N/A GRACE THERAPEUTICS INC | $1M | 476.2K | 0.33% | — |
| 34 | P POLYPID LTD | $933K | 177.0K | 0.30% | — |
| 35 | ? N/A SPDR SERIES TRUST | $925K | 250.0K | 0.30% | — |
| 36 | S STATE STR SPDR S&P 500 ETF T | $382K | 100.0K | 0.12% | — |
| 37 | ? N/A VERASTEM INC | $357K | 293.6K | 0.11% | — |
| 38 | ? N/A INVESCO QQQ TR | $258K | 50.0K | 0.08% | — |
| 39 | P PEPGEN INC | $257K | 412.7K | 0.08% | — |
| 40 | O ONKURE THERAPEUTICS INC | $184K | 67.5K | 0.06% | — |
| 41 | ? N/A XERIS BIOPHARMA HOLDINGS INC | $160K | 400.0K | 0.05% | — |
| 42 | ? N/A SELLAS LIFE SCIENCES GROUP INC | $127K | 618.8K | 0.04% | — |
| 43 | C BRISTOL-MYERS SQUIBB CO | $84K | 20.0K | 0.03% | — |
| 44 | ? N/A EYEPOINT INC | $50K | 701.7K | 0.02% | — |
| 45 | C CORCEPT THERAPEUTICS INC | $24K | 10.0K | 0.01% | — |
| 46 | ? N/A CELLDEX THERAPEUTICS INC | $0 | 128.8K | 0.00% | — |